MedTrace Logo

Gross Myofascial Release in Cervical Radiculopathy Pat

NCT04946097 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2021-08-09

No results posted yet for this study

Summary

To investigate the Effect of gross Myofascial Release on pain and function in cervical radiculopathy patients. BACKGROUND: cervical radiculopathy is considered serious problems causing neck pain \& radiating pain which affect physical inactivity and function of a patient, thus gross Myofascial Release is a form of manual therapy technique that has a profound effect upon the musculoskeletal system.

HYPOTHESES:

This study hypothesized that:

gross Myofascial Release on pain and function in cervical radiculopathy patients RESEARCH QUESTION: Is there an effect of gross Myofascial Release on pain and function in cervical radiculopathy patients?

Conditions

  • Cervical Radiculopathy

Interventions

OTHER

gross Myofascial Release

Gross Myofascial Release : is amanual technique in form of Stretch of the Posterior Cervical Musculature and Gross stretch of gross Myofascial Release upper quarter: Arm Pull for duration of 10-15 min per session each stretch position was healed for 90sec

OTHER

conventional selected exercise program

stretching exercises for cervical muscles and pectoralis major and source of heat in form of hot packs for 15 minutes

DEVICE

Transcutaneous electrical nerve stimulation (TENS)

Transcutaneous electrical nerve stimulation (TENS) is a method of pain relief involving the use of electrical current, the electrode placement on the course of pain for 15 minutes

Sponsors & Collaborators

  • October 6 University

    lead OTHER

Principal Investigators

  • Hosam M Metwally, PHD · lecturer , department of Neuromuscular Disorders and its surgery, faculty of physical therapy O6U physical therapy

  • Lama Saad ED Mahmoud, PHD · October 6 University

  • Sobhy M Aly, PHD · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-01
Primary Completion
2021-07-01
Completion
2021-07-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04946097 on ClinicalTrials.gov